Iovance Biotherapeutics, Inc.
Immuno Oncology • Autologous Cell Therapy • Tumor Infiltrating Lymphocytes (TIL) • Novel Cancer Immunotherapies • cell therapy
Senior Medical Director
3 days ago
Iovance Biotherapeutics, Inc.
Immuno Oncology • Autologous Cell Therapy • Tumor Infiltrating Lymphocytes (TIL) • Novel Cancer Immunotherapies • cell therapy
Description
• Overseeing the direction, planning, execution, and interpretation of clinical trials and data collection. • Directing protocol implementation and managing program development across various disciplines. • Monitoring clinical trials and supporting data analysis and communication with commercial teams.
Requirements
• Board Certified MD with minimum 5 years of industry experience. • Effective oral and written communication skills and excellent interpersonal skills with demonstrated ability to work with a team. • Demonstrated independence, initiative and the ability to work well in a fast-paced environment.
Apply NowSimilar Jobs
6 days ago
Lead mental health services and strategic initiatives at Teladoc Health. Enhance quality and accessibility across the nation.
🇺🇸 United States – Remote
💵 $270k - $300k / year
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🗽 H1B Visa Sponsor
6 days ago
Oversee the strategic clinical execution of primary and specialty care services. Transform healthcare experiences through innovative practices at Teladoc Health.
🇺🇸 United States – Remote
💵 $270k - $300k / year
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🗽 H1B Visa Sponsor
November 26
Drive clinical development of radiopharmaceuticals for cancer treatments at RayzeBio. Collaborate with multidisciplinary teams and regulatory authorities.
🇺🇸 United States – Remote
💵 $297.9k - $403k / year
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🗽 H1B Visa Sponsor
November 22
Drive clinical development strategy for antibody therapies targeting immunological diseases at Spyre Therapeutics.
November 22
Senior Medical Director providing strategic counsel in medical communications for healthcare clients. Foster growth and develop high quality educational content.